Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2007European Journal of Endocrinology

Treatment of Graves’ disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMario SalviFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoGVGuia VannucchiIRCCS Istituto Auxologico ItalianoICIrene CampiIRCCS Istituto Auxologico Italiano

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Salvi et al. (2007) studied this question.

synapsesocial.com/papers/6a712bada2d7cf2e39c2c386https://doi.org/10.1530/eje.1.02325
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Autoimmune Diseases2001 · 1,048 citations
  2. 2T Helper Type 1 and Type 2 Cytokines Exert Divergent Influence on the Induction of Prostaglandin E2 and Hyaluronan Synthesis by Interleukin-1β in Orbital Fibroblasts: Implications for the Pathogenesis of Thyroid-Associated Ophthalmopathy2005 · 97 citations
  3. 3B Cells, Be Gone — B-Cell Depletion in the Treatment of Rheumatoid Arthritis2004 · 80 citations
  4. 4Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy1997 · 1,008 citations
  5. 5Randomized, Single Blind Trial of Intravenous<i>versus</i>Oral Steroid Monotherapy in Graves’ Orbitopathy2005 · 422 citations